StemGen, Inc. reported earnings results for the second quarter and six months ended December 31, 2021. For the second quarter, the company reported sales was USD 0.02 million compared to USD 0.015 million a year ago. Net loss was USD 0.081389 million compared to USD 0.11484 million a year ago.
For the six months, sales was USD 0.02 million compared to USD 0.039 million a year ago. Net loss was USD 0.217416 million compared to USD 0.201514 million a year ago.